Navigation Links
Estrogen-only HRT may increase risk of asthma after menopause
Date:2/7/2010

Oestrogen-only hormone replacement therapy (HRT) may increase the risk of developing asthma after the menopause, suggests a large scale study published ahead of print in the journal Thorax.

The authors base their findings on 57, 664 women, who were quizzed about their use of HRT and development of asthma symptoms every two years between 1990 and 2002.

All the women were taking part in the French E3N study, which includes almost 100, 000 women born between 1925 and 1950, and is the French component of the European Prospective Investigation into Cancer and Nutrition (EPIC).

None of these women had asthma when menopausal symptoms began.

The monitoring period equated to 495,448 person years in all, of which over a third was accounted for by women who had not used HRT (35.7%).

Previous users made up 4.5% while information on how long HRT was used was not known for a further 4%. Of the remainder, just under 56% were recent users of HRT.

Between 1990 and 2002, 569 women were newly diagnosed with asthma, corresponding to a rate of 1.15 cases per 1000 women a year.

Compared with women who had never used any form of HRT, those who did use it were 21% more likely to develop asthma, after adjusting for factors likely to influence the results.

Almost one in 10 women with a natural menopause (9.4%), and more than one in four (28%) of those with a surgically induced menopause, used HRT containing oestrogen alone.

The risk of asthma was significant only among those using oestrogen alone. Among these women the overall risk of asthma was 54% higher than among those who had never used any form of HRT.

Oestrogen only users who had never smoked and those who had had some form of allergy before their asthma diagnosis were at greatest risk of developing asthma 80% and 86% higher, respectively.

A small increased risk for asthma was also seen in women using combined oestrogen and progesterone HRT who were either non smokers or who had had some form of allergic reaction in the past.

Previous research has suggested that female hormones may have a role in the development and severity of asthma, say the authors.

The disease is more common in young women after they have started having periods, while hospital admissions for asthma are more common among women than men.

The severity of asthma also varies throughout the menstrual cycle and during pregnancy, and the incidence of the disease tends to fall after the menopause, except among those who put on a lot of weight, the authors point out.

They conclude that while their findings point to an increased risk of asthma, this must be judged in "the light of all the other health effects of HRT use, including its beneficial effect on the quality of life of menopausal women."


'/>"/>

Contact: Emma Dickinson
edickinson@bmjgroup.com
44-207-383-6529
BMJ-British Medical Journal
Source:Eurekalert

Related medicine news :

1. Smoking may strongly increase long-term risk of eye disease
2. Diabetes appears to increase risk of death for patients with acute coronary syndromes
3. Prophylactic cranial irradiation in small cell lung cancer significantly increases survival
4. Fat on chest and upper back increases risk of insulin resistance
5. Ability to cope with stress can increase good cholesterol in older white men, study finds
6. Handling Stress Properly Increases Good Cholesterol
7. High alcohol consumption increases stroke risk among Chinese men
8. High alcohol consumption increases stroke risk, Tulane study says
9. Increased distance to physician associated with thicker skin cancer at diagnosis
10. Genetic predisposition increases childhood asthma risk
11. Smoking increases risks for head and neck cancers for men and women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... McLean, Virginia (PRWEB) , ... April 24, 2017 ... ... have announced that they are seeking public support to bring their novel lifesaving ... in appearance, wearable device packed with medical-grade sensors, specially designed to read a ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... telehealth industry, announces the company’s VideoMedicine mobile platform has launched Quick Care, a ... hours a day, Quick Care provides patients with the option to request and ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... opioid overdose deaths now claim the lives of 62 Americans each day.(1) Yet ... against drug manufacturers, distributors, pharmacies and prescribers by more than half.(2) Novus ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... recognize elevated anxiety levels in people with addiction who are served by MAP’s ... a biosensing wearable device that monitors heart and breath rates to identify anxiety ...
(Date:4/24/2017)... Boston, MA (PRWEB) , ... April 24, 2017 ... ... the cardiovascular health of individuals with HIV because it is not known to ... statins may have favorable effects to both lower cholesterol levels and dampen inflammation ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), a ... Urology, Uro/Gyn and Gynecology markets with innovative and ... joined the Company as Senior Vice President, Marketing ... Mr. Keswani will report directly to Darin ... organization is delighted that Ash has joined the ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology: